Approaches to Fertility Preservation for Young Women With Breast Cancer.

Authors : Razeti MG, Soldato D, Arecco L, Levaggi A, Puglisi S, Solinas C, Agostinetto E, Spinaci S, Lapuchesky L, Genova C, Massarotti C, Lambertini M
Year : 2023
Journal : Clin Breast Cancer
Volume : 23
Pages : 241-248

Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer.

Authors : Agostinetto E, Losurdo A, Nader-Marta G, Santoro A, Punie K, Barroso R, Popovic L, Solinas C, Kok M, de Azambuja E, Lambertini M
Year : 2022
Journal : Expert Opin Investig Drugs
Volume : 31
Pages : 567-591

Thromboembolism and Immune Checkpoint Blockade in Cancer Patients: An Old Foe for New Research.

Authors : Langouo Fontsa M, Aiello MM, Migliori E, Scartozzi M, Lambertini M, Willard-Gallo K, Solinas C
Year : 2022
Journal : Target Oncol
Volume : 17
Pages : 497-505

Role of cardiac MRI in the diagnosis of immune checkpoint inhibitor-associated myocarditis.

Authors : Cau R, Solinas C, De Silva P, Lambertini M, Agostinetto E, Scartozzi M, Montisci R, Pontone G, Porcu M, Saba L
Year : 2022
Journal : Int J Cancer
Volume : 151
Pages : 1860-1873

Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity.

Authors : Noël G, Fontsa ML, Garaud S, De Silva P, de Wind A, Van den Eynden GG, Salgado R, Boisson A, Locy H, Thomas N, Solinas C, Migliori E, Naveaux C, Duvillier H, Lucas S, Craciun L, Thielemans K, Larsimont D, Willard-Gallo K
Year : 2021
Journal : J Clin Invest
Volume : 131

A review of immune checkpoint blockade in breast cancer.

Authors : Pellegrino B, Tommasi C, Cursio OE, Musolino A, Migliori E, De Silva P, Senevirathne TH, Schena M, Scartozzi M, Farci D, Willard-Gallo K, Solinas C
Year : 2021
Journal : Semin Oncol
Volume : 48
Pages : 208-225

Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune Suppression.

Authors : Pellegrino B, Hlavata Z, Migali C, De Silva P, Aiello M, Willard-Gallo K, Musolino A, Solinas C
Year : 2021
Journal : Mol Diagn Ther
Volume : 25
Pages : 409-424

Targeting CTLA-4 in cancer: Is it the ideal companion for PD-1 blockade immunotherapy combinations?

Authors : De Silva P, Aiello M, Gu-Trantien C, Migliori E, Willard-Gallo K, Solinas C
Year : 2021
Journal : Int J Cancer
Volume : 149
Pages : 31-41

The rationale behind targeting the ICOS-ICOS ligand costimulatory pathway in cancer immunotherapy.

Authors : Solinas C, Gu-Trantien C, Willard-Gallo K
Year : 2020
Journal : ESMO Open
Volume : 5

Radiomics and radi-…omics" in cancer immunotherapy: a guide for clinicians."

Authors : Porcu M, Solinas C, Mannelli L, Micheletti G, Lambertini M, Willard-Gallo K, Neri E, Flanders AE, Saba L
Year : 2020
Journal : Crit Rev Oncol Hematol
Volume : 154
Pages : 103068

Programmed Cell Death-Ligand 2: A Neglected But Important Target in the Immune Response to Cancer?

Authors : Solinas C, Aiello M, Rozali E, Lambertini M, Willard-Gallo K, Migliori E
Year : 2020
Journal : Transl Oncol
Volume : 13
Pages : 100811

Immune Checkpoint Inhibitor-Induced Pancreatic Injury: Imaging Findings and Literature Review.

Authors : Porcu M, Solinas C, Migali C, Battaglia A, Schena M, Mannelli L, Addeo A, Willard-Gallo K, Saba L
Year : 2020
Journal : Target Oncol
Volume : 15
Pages : 25-35

Breast cancer vaccines: Heeding the lessons of the past to guide a path forward.

Authors : Solinas C, Aiello M, Migliori E, Willard-Gallo K, Emens LA
Year : 2020
Journal : Cancer Treat Rev
Volume : 84
Pages : 101947

Homologous Recombination Repair Deficiency and the Immune Response in Breast Cancer: A Literature Review.

Authors : Pellegrino B, Musolino A, Llop-Guevara A, Serra V, De Silva P, Hlavata Z, Sangiolo D, Willard-Gallo K, Solinas C
Year : 2020
Journal : Transl Oncol
Volume : 13
Pages : 410-422

Excision Repair Cross Complementation Group 1 Single Nucleotide Polymorphisms and Nivolumab in Advanced Non-Small Cell Lung Cancer.

Authors : Aiello MM, Solinas C, Santoni M, Battelli N, Restuccia N, Latteri F, Paratore S, Verderame F, Albanese GV, Bruzzi P, Soto Parra HJ
Year : 2020
Journal : Front Oncol
Volume : 10
Pages : 1167

Significance of TIM3 expression in cancer: From biology to the clinic.

Authors : Solinas C, De Silva P, Bron D, Willard-Gallo K, Sangiolo D
Year : 2019
Journal : Semin Oncol
Volume : 46
Pages : 372-379

Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer.

Authors : Garaud S, Buisseret L, Solinas C, Gu-Trantien C, de Wind A, Van den Eynden G, Naveaux C, Lodewyckx JN, Boisson A, Duvillier H, Craciun L, Ameye L, Veys I, Paesmans M, Larsimont D, Piccart-Gebhart M, Willard-Gallo K
Year : 2019
Journal : JCI Insight
Volume : 5

LAG3: The Biological Processes That Motivate Targeting This Immune Checkpoint Molecule in Human Cancer.

Authors : Solinas C, Migliori E, De Silva P, Willard-Gallo K
Year : 2019
Journal : Cancers (Basel)
Volume : 11

FOXP1 negatively regulates tumor infiltrating lymphocyte migration in human breast cancer.

Authors : De Silva P, Garaud S, Solinas C, de Wind A, Van den Eyden G, Jose V, Gu-Trantien C, Migliori E, Boisson A, Naveaux C, Duvillier H, Craciun L, Larsimont D, Piccart-Gebhart M, Willard-Gallo K
Year : 2019
Journal : EBioMedicine
Volume : 39
Pages : 226-238

Targeting PD-1 in cancer: Biological insights with a focus on breast cancer.

Authors : Solinas C, Aiello M, De Silva P, Gu-Trantien C, Migliori E, Willard-Gallo K
Year : 2019
Journal : Crit Rev Oncol Hematol
Volume : 142
Pages : 35-43